Full article: Novel multi-target ligands of dopamine and serotonin

IJMS, Free Full-Text

Ligand-directed bias of G protein signaling at the dopamine D2 receptor - ScienceDirect

IJMS, Free Full-Text

Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism

Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens - ScienceDirect

Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms

Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Automated design and optimization of multitarget schizophrenia drug candidates by deep learning - ScienceDirect

Frontiers Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications

Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer